CrossTalk Research CrossTalk Research

Patents

Current US patent pending application #61/688,817 - self programmable biomedical device (SPBD), portable or stationary, that maintains a patient's life stability by:

  • Monitoring and treating chronic diseases (diabetes, epilepsy, hypertension, etc.)
  • Controlling sudden changes in major life-threatening physiological parameters.


SPBD can be set to respond by either sending an informational alert to a patient and/ or medical personnel or be set to respond automatically.

Previously obtained US patents by Dr. Eydelman:

  • U.S. Patent Number 4,525,775
    An adaptive control system incorporating self-teaching and self-programming features.

  • U.S. Patent Number 4,653,089
    A personal telephone adapter - first world wide patent in IVR field,

  • U.S. Patent Number 7,573,432

  • U.S. Patent Number 6,847,210

  • U.S. Patent Number 6,727,698

  • U.S. Patent Number 6,636,040

  • U.S. Patent Number 6,229,310

  • U.S. Patent Number 6,028,429

  • U.S. Patent Number 5,939,883

  • U.S. Patent Number 5,050,605